Flyer

Farmacologia y Toxicologia

  • ISSN: 2174-8365
  • Journal h-index: 1
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • OCLC- WorldCat
  • Euro Pub
  • SHERPA ROMEO
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

Accelerating Drug Development for COVID-19: A Race against the Pandemic

Gibran Herman*

The COVID-19 pandemic necessitated an urgent and accelerated approach to drug development. This abstract highlights the remarkable efforts made in developing drugs for COVID-19, including collaboration among scientists, repurposing existing drugs, and the triumph of vaccine development. The global scientific community joined forces, sharing knowledge and data to understand the virus better. Repurposing existing drugs allowed for faster clinical trials and promising results. The development and distribution of vaccines became a historic achievement, significantly reducing the spread and severity of the virus. Challenges such as safety assessments and equitable distribution were encountered. Lessons learned from this endeavor will shape future drug development and global pandemic preparedness. The COVID-19 drug development race showcases human resilience, scientific advancement, and the power of collaboration.

Keywords

Covid-19; Drug development; Existing drugs

Published Date: 2023-06-30; Received Date: 2023-06-01